News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

AL46- Growth and Tolerance of Preterm Infants Fed an Experimental Human Milk Fortifier

Study Status:

Not yet active

Contact Information:

(956) 362-2396

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is to evaluate the growth and tolerance of preterm infants fed a next generation Similac HMF, compared to the current standard of care of Similac HMF.


Principal Investigator
Dynio Honrubia, MD
Luis Cantu Jr.
Abbott Nutrition
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram